Tubiera, Jmee Maxel L.

HRN: 15-63-53  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/25/2024
CEFTRIAXONE 1G (VIAL)
03/25/2024
04/01/2024
IV
1.9g
OD
T/C PMBO
Waiting Final Action 
03/25/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/25/2024
04/01/2024
IV
190mg
Q8H
T/C PMBO
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: